# Statistical Analysis of the Parkinsonâ€™s Voice Dataset  

## ğŸ“– Project Overview  
This project applies a **5-step statistical analysis workflow** to the [UCI Parkinsonâ€™s Voice Dataset](https://archive.ics.uci.edu/ml/datasets/parkinsons).  
The dataset contains **22 voice features** extracted from sustained phonation recordings, along with a **status label** (1 = Parkinsonâ€™s Disease, 0 = healthy).  

The goal:  
- Explore how acoustic features differ between PD and controls  
- Identify **potential biomarkers** for diagnosis  
- Demonstrate statistical and machine learning techniques in a health data context  

---

## ğŸ› ï¸ Workflow  

### ğŸ”¹ Step 1: Descriptive Statistics & Distribution Checks  
- Explored feature distributions (histograms, boxplots, QQ-plots).  
- Checked **normality (Shapiroâ€“Wilk)** and **variance equality (Leveneâ€™s test)**.  
- Found that jitter/shimmer are highly skewed, HNR closer to normal.  

ğŸ“Œ Deliverable: Summary of which features are approximately normal vs. skewed.  

---

### ğŸ”¹ Step 2: Parametric vs Non-Parametric Testing  
- Compared PD vs. healthy for each feature.  
- Chose **Mannâ€“Whitney U** for most (non-normal) features, Welchâ€™s t-test for rare normal ones.  
- Applied **multiple testing correction** (Benjaminiâ€“Hochberg FDR).  

ğŸ“Œ Result: **Spread1, PPE, and MDVP:APQ** emerged as most significant (p_FDR < 1e-9).  

---

### ğŸ”¹ Step 3: Confidence Intervals & Hypothesis Testing  
- Computed **bootstrap 95% confidence intervals** for medians.  
- Confirmed significant differences (Mannâ€“Whitney p-values).  
- Quantified effect sizes (rank-biserial correlations).  

ğŸ“Œ Example:  
- Spread1: Healthy median -6.83 vs PD -5.44, effect size 0.79 â†’ **very strong difference**.  

---

### ğŸ”¹ Step 4: Effect Sizes, Errors & Power  
- Calculated **Cohenâ€™s d** for top features (all > 0.9 â†’ very large).  
- Ran **power analysis** (statsmodels):  
  - Only ~6â€“18 samples per group needed to detect these differences with 80% power.  
- Discussed **Type I (false positives)** and **Type II (false negatives)** in this context.  

ğŸ“Œ Conclusion: Dataset is more than sufficient to detect clinically meaningful differences.  

---

### ğŸ”¹ Step 5: Correlation & Regression  

- **Spearman correlation heatmap** â†’ revealed redundancy (e.g., shimmer/APQ cluster, jitter family, Spread1 â‰ˆ PPE).  
- **Simple regressions** (e.g., PPE ~ Spread1) showed near-linear dependence (RÂ² â‰ˆ 0.95).  
- **Logistic regression with VIF pruning**: Spread1, PPE, APQ remain robust predictors.  
- **Regularization (L1/L2)** confirmed that a small subset of features suffices for high predictive accuracy (AUC â‰ˆ 0.95).  

ğŸ“Œ Deliverable: Odds ratios, ROC curves, and regularized feature selection results.  

---

## ğŸ”‘ Key Insights  
- PD patients show **greater voice irregularity** (jitter, shimmer, APQ) and **nonlinear frequency variation** (Spread1, PPE).  
- A **compact model with 3â€“4 features** achieves excellent discrimination (AUC ~0.95).  
- Confirms known biomarkers while showcasing a reproducible, researcher-style workflow.  

---

## ğŸ“‚ Repo Structure  
parkinsons_stats_project/
â”‚
â”œâ”€â”€ data/ # Parkinsonâ€™s dataset (.csv, .names)
â”œâ”€â”€ notebooks/ # Jupyter notebook
â”œâ”€â”€ summary.csv # Final statistical summary tables
â””â”€â”€ README.md # This file

---

## ğŸ§° Methods & Tools  
- **Python**: pandas, numpy, scipy, statsmodels, sklearn, seaborn, matplotlib  
- **Statistics**: Shapiroâ€“Wilk, Leveneâ€™s test, Mannâ€“Whitney U, bootstrap CIs, Cohenâ€™s d, power analysis  
- **ML**: Logistic regression, L1/L2 regularization, ROC/AUC  

---

## ğŸ“œ References  
- Little MA, McSharry PE, Roberts SJ, Costello DAE, Moroz IM.  
  *Exploiting Nonlinear Recurrence and Fractal Scaling Properties for Voice Disorder Detection*.  
  BioMedical Engineering OnLine 2007, 6:23.  

- UCI Machine Learning Repository: [Parkinsonâ€™s Dataset](https://archive.ics.uci.edu/ml/datasets/parkinsons)  

---

This project demonstrates how to move from **EDA â†’ statistical testing â†’ effect size â†’ regression modeling** in a **healthcare context**.  
It can serve as a **template for biomarker discovery projects** in biotech, neuroscience, and beyond.  
